120 related articles for article (PubMed ID: 13243982)
1. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
HAMBLY CK; ROBERTSON TI
Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
[No Abstract] [Full Text] [Related]
2. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
3. Treatment of lymphomatous diseases with triethylene melamine.
MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I
Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963
[No Abstract] [Full Text] [Related]
4. [Clinical trials with triethylene melamine].
FERRARI M; KASDORF H
Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
[No Abstract] [Full Text] [Related]
5. Triethylene melamine in the treatment of neoplastic disease.
RUNDLES RW; BARTON WB
Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
[No Abstract] [Full Text] [Related]
6. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H
Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965
[No Abstract] [Full Text] [Related]
7. The clinical use of triethylene melamine.
KRAVITZ SC; DIAMOND HD; CRAVER LF
Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
[No Abstract] [Full Text] [Related]
8. [Immediate results of triethylene melamine therapy of neoplastic diseases].
LENTI G; GAVOSTO F
Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386
[No Abstract] [Full Text] [Related]
9. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
RUVIDIC R; NIKOLIC J
Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
[No Abstract] [Full Text] [Related]
10. Treatment of Hodgkin's disease and the lymphosarcomas.
MEYER OO
J Am Med Assoc; 1954 Jan; 154(2):114-20. PubMed ID: 13108678
[No Abstract] [Full Text] [Related]
11. TRIETHYLENE-MELAMINE.
Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
[No Abstract] [Full Text] [Related]
12. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
KIELER J
Acta radiol; 1951 Dec; 36(6):461-8. PubMed ID: 14902587
[No Abstract] [Full Text] [Related]
13. Clinical and hematologic effects of triethylene melamine.
AXELROD AR; BERMAN L; MURPHY RV
Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437
[No Abstract] [Full Text] [Related]
14. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
NEUMANN C
Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
[No Abstract] [Full Text] [Related]
15. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas.
ROTTINO A
N Y State J Med; 1952 Feb; 52(3):346-8. PubMed ID: 14899689
[No Abstract] [Full Text] [Related]
16. [Triethylenemelamine (TEM) in lymphatic leukemia].
PRIBILLA W; STOLLBERG G
Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
[No Abstract] [Full Text] [Related]
17. Some clinical experience in the use of triethylene melamine (TEM).
HAMERMAN DJ; MELAMED S
J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
[No Abstract] [Full Text] [Related]
18. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
HANSEN PB; BICHEL J
Acta radiol; 1951 Dec; 36(6):469-76. PubMed ID: 14902588
[No Abstract] [Full Text] [Related]
19. [Experimentation with actinomycin].
HUGUENIN R; TRUHAUT R; BOURDIN JS
Presse Med (1893); 1954 May; 62(35):740. PubMed ID: 13177453
[No Abstract] [Full Text] [Related]
20. [Value and action of cytostatics in malignant lymphatic system diseases].
FLEISCHHACKER H; STACHER A
Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
